文献速递瓣膜外科主动脉外科

Bentall术后感染性心内膜炎再手术的短期与中期结局:多中心注册研究

Surgery for Bentall endocarditis: short- and midterm outcomes from a multicentre registry.
PubMed 文献 · Eur J Cardiothorac Surg · 2020-01-01

围术期死亡率为15%,术后并发症包括肾衰竭19%、大出血14%、肺衰竭14%、脓毒症11%和多器官衰竭8%。5年和8年生存率分别为75±6%和71±7%,感染复发3例。

要点

  • Bentall术后感染性心内膜炎再手术围术期死亡率15%,并发症发生率高。
  • 5年及8年生存率分别为75±6%和71±7%,感染复发少见(3例)。

核心结论

  • 再手术治疗Bentall术后感染性心内膜炎有效,但围术期死亡率和并发症发生率较高,感染复发似乎不常见。

主要发现

  • 术前12%患者处于脓毒性休克,63%存在左心室-主动脉 discontinuity,12%累及二尖瓣。
  • 最常见病原体为金黄色葡萄球菌(22%)和链球菌(14%)。
  • 再手术中位间隔30个月(1-221个月),再Bentall生物管道41%、机械瓣复合管道33%、生物瓣复合管道19%、同种移植物6%。
  • 住院死亡率15%,术后并发症包括肾衰竭19%、大出血14%、肺衰竭14%、脓毒症11%、多器官衰竭8%。

临床怎么用

  • 对于Bentall术后感染性心内膜炎,再手术是有效治疗选择,但需警惕高围术期风险,尤其急诊手术患者。
  • 术后应密切监测肾功能、出血、肺功能及感染复发。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Endocarditis after the Bentall procedure is a severe disease often complicated by a pseudoaneurysm or mediastinitis. Reoperation is challenging but conservative therapy is not effective. The aim of this study was to assess short- and midterm outcomes of patients reoperated on for Bentall-related endocarditis. METHODS: Seventy-three patients with Bentall procedure-related endocarditis were recorded in the Italian registry. The mean age was 57 ± 14 years and 92% were men; preoperative comorbidities included hypertension (45%), diabetes (12%) and renal failure (11%). The logistic EuroSCORE was 25%; the EuroSCORE II was 8%. RESULTS: Preoperatively, 12% of the patients were in septic shock; left ventricular-aortic discontinuity was present in 63% and mitral valve involvement occurred in 12%. The most common pathogens were Staphylococcus aureus (22%) and Streptococci (14%). Reoperations after a median interval of 30 months (1-221 months) included a repeat Bentall with a bioconduit (41%), a composite mechanical (33%) or biological valved conduit (19%) and a homograft (6%). In 1 patient, a heart transplant was required (1%); in 12%, a mitral valve procedure was needed. The hospital mortality rate was 15%. The postoperative course was complicated by renal failure (19%), major bleeding (14%), pulmonary failure (14%), sepsis (11%) and multiorgan failure (8%). At multivariate analysis, urgent surgery was a risk factor for early death [hazard ratio 20.5 (1.9-219)]. Survival at 5 and 8 years was 75 ± 6% and 71 ± 7%, with 3 cases of endocarditis relapse. CONCLUSIONS: Surgery is effective in treating endocarditis following the Bentall procedure although it is associated with high perioperative mortality and morbidity rates. Endocarditis relapse seems to be uncommon.

来源:Eur J Cardiothorac Surg,查看原文。版权归原作者所有。

引用

  1. Sponga S, Di Mauro M, Malvindi PG, et al. Surgery for Bentall endocarditis: short- and midterm outcomes from a multicentre registry. Eur J Cardiothorac Surg. 2020. PMID: 32417897. doi:10.1093/ejcts/ezaa136

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。